Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER IN RHEUMATOID ARTHRITIS PATIENTS Dore, R. K., Antonova, J., Huan, H., Gorritz, M., Genovese, M. C. BMJ PUBLISHING GROUP. 2019: 700
View details for DOI 10.1136/annrheumdis-2019-eular.1848
View details for Web of Science ID 000472207102120